课题基金 / 基金详情

SPONTANEOUSLY BIOTINYLATED LENTIVIRAL VECTORS FOR ENVELOPE INDEPENDENT TARGETING OF INFECTION

SPONTANEOUSLY BIOTINYLATED LENTIVIRAL VECTORS FOR ENVELOPE INDEPENDENT TARGETING OF INFECTION
用于包膜独立靶向感染的自发生物素化慢病毒载体
批准号:
BB/D014301/1
负责人:
Farzin Farzaneh
金额:
$25.12万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --

项目摘要

项目成果

Farzin Farzaneh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As a result of a BBSRC funded project we have generated a new 293T based cell line specifically for the production of metabolically biotin labelled lentiviral vectors. These bio-lentiviral vectors have been demonstrated to efficiently complex with streptavidin paramagnetic particles. This combination has resulted in the most efficient purification and concentration method yet described for lentiviral vectors. We wish to use the platform of these new biotin-lentiviral packaging cells to exemplify their value to the gene therapy community. By virtue of their biotinylated surface these viruses can be attached to specific cell binding proteins so that they can be targeted to specific sites of disease. Their unique properties also allow us to increase our knowledge of the cell derived accessory proteins that are also resident on the lentiviral surface. Information on the influence of these proteins on the process of lentiviral infection can then be applied to more efficient targeting of gene therapy vectors to specific sites of infection.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1182/blood.v130.suppl_1.887.887
发表时间: 2017-12
期刊: Blood
影响因子: 20.3
作者: [C. Graham;D. Yallop;A. Jóźwik;P. Patten;A. Dunlop;R. Ellard;Orla Stewart;V. Potter;V. Metaxa;S. Kassam;F. Farzaneh;S. Devereux;A. Pagliuca;A. Zinai;F. Binlich;S. Dupouy;Anne Philippe;S. Balandraud;F. Dubois;C. Konto;Premal H. Patel;G. Mufti;R. Benjamin]
通讯作者: C. Graham;D. Yallop;A. Jóźwik;P. Patten;A. Dunlop;R. Ellard;Orla Stewart;V. Potter;V. Metaxa;S. Kassam;F. Farzaneh;S. Devereux;A. Pagliuca;A. Zinai;F. Binlich;S. Dupouy;Anne Philippe;S. Balandraud;F. Dubois;C. Konto;Premal H. Patel;G. Mufti;R. Benjamin
Allogeneic Anti-CD19 CAR T Cells Manufactured from Healthy Donors Provide a Unique Cellular Product with Distinct Phenotypic Characteristics Compared to CAR T Cells Generated from Patients with Mature B Cell Malignancies
与来自成熟 B 细胞恶性肿瘤患者的 CAR T 细胞相比,来自健康捐赠者的同种异体抗 CD19 CAR T 细胞提供了具有独特表型特征的独特细胞产品
DOI: 10.1182/blood-2019-123018
发表时间: 2019
期刊: Blood
影响因子: 20.3
作者: [Graham C]
通讯作者: Graham C
Efficient Ex Vivo Expansion of ?d T-Cells from AML Patients Requires Elimination of Circulating Leukemic Blasts
AML 患者体内 ?d T 细胞的高效体外扩增需要消除循环白血病母细胞
DOI: 10.36959/486/327
发表时间: 2020
期刊: Advances in Leukemia Research and Treatment
影响因子: --
作者: [Ana C P]
通讯作者: Ana C P
Large scale lentiviral vector production
  • 批准号:
    BB/N003853/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $74.52万
  • 财政年份:
    2015
  • 负责人:
    Farzin Farzaneh
  • 依托单位:
BRIC: Packaging cell lines for inherently manufacturable viral vectors
  • 批准号:
    BB/E005896/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $32.02万
  • 财政年份:
    2007
  • 负责人:
    Farzin Farzaneh
  • 依托单位:
Second Generation Bio-Lentivir Packaging Cell Line for Facile Lentivirus Production
  • 批准号:
    EP/D500346/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $25.5万
  • 财政年份:
    2006
  • 负责人:
    Farzin Farzaneh
  • 依托单位:
海外基金